PFK158, a specific inhibitor of Fructose 2,6-Bisphosphatase 3 (PFKFB3), effectively suppresses glycolysis rate to impede cancer cell proliferation and enhances the sensitivity of cancer cells towards carboplatin and cisplatin. The gene discussed is PFKFB3; the disease is cancer.